Research/Scholarly/Creative Works

Journal Articles

• Baxter-Parker G., Roffe L., Cross S., Frampton C., Hooper GJ. and Gieseg SP. (2019) Knee replacement surgery significantly elevates the urinary inflammatory biomarkers neopterin and 7,8-dihydroneopterin. Clinical Biochemistry 63: 39-45. http://dx.doi.org/10.1016/j.clinbiochem.2018.11.002.

• Bateman CJ., Knight D., Brandwacht B., Mc Mahon J., Healy J., Panta R., Aamir R., Rajendran K., Moghiseh M. and Ramyar M. (2018) MARS-MD: rejection based image domain material decomposition. JOURNAL OF INSTRUMENTATION 13 ARTN P05020 http://dx.doi.org/10.1088/1748-0221/13/05/P05020.

• Gieseg SP., Baxter-Parker G. and Lindsay A. (2018) Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing? Antioxidants (Basel) 7(7) http://dx.doi.org/10.3390/antiox7070080.

• Marks ECA., Wilkinson TM., Frampton CM., Skelton L., Pilbrow AP., Yandle TG., Pemberton CJ., Doughty RN., Whalley GA. and Ellis CJ. (2018) Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.. BMC Cardiovasc Disord 18(1): 169. http://dx.doi.org/10.1186/s12872-018-0894-1.

• Prebble H., Cross S., Marks E., Healy J., Searle E., Aamir R., Butler A., Roake J., Hock B. and Anderson N. (2018) Induced macrophage activation in live excised atherosclerotic plaque.. Immunobiology 223(8-9): 526-535. http://dx.doi.org/10.1016/j.imbio.2018.03.002.

• Lindsay A., Carr S., Cross S., Petersen C., Lewis JG. and Gieseg SP. (2017) The physiological response to cold-water immersion following a mixed martial arts training session. Applied Physiology, Nutrition, and Metabolism 42(5): 529-536. http://dx.doi.org/10.1139/apnm-2016-0582.

• Lindsay A., Lewis JG., Gill N., Draper N. and Gieseg SP. (2017) No relationship exists between urinary NT-proBNP and GPS technology in professional rugby union. Journal of Science and Medicine in Sport 20(8): 790-794. http://dx.doi.org/10.1016/j.jsams.2016.11.017.

• Lindsay A., Petersen C., Blackwell G., Ferguson H., Parker G., Steyn N. and Gieseg SP. (2017) The effect of 1 week of repeated ischaemic leg preconditioning on simulated Keirin cycling performance: a randomised trial. BMJ Open Sport & Exercise Medicine 3(1) e000229: 9. http://dx.doi.org/10.1136/bmjsem-2017-000229.

• Roche J., Turnbull MH., Guo Q., Novák O., Späth J., Gieseg SP., Jameson PE. and Love J. (2017) Coordinated nitrogen and carbon remobilization for nitrate assimilation in leaf, sheath and root and associated cytokinin signals during early regrowth of Lolium perenne. Annals of Botany 119(8): 1353-1364. http://dx.doi.org/10.1093/aob/mcx014.

• Shchepetkina AA., Hock BD., Miller A., Kennedy MA. and Gieseg SP. (2017) Effect of 7,8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages. International Journal of Biochemistry and Cell Biology 87: 27-33. http://dx.doi.org/10.1016/j.biocel.2017.03.017.

• Shchepetkina AA., Hock BD., Miller A., Kennedy MA. and Gieseg SP. (2017) Effect of 7,8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages. The International Journal of Biochemistry & Cell Biology 87 C: 27-33. 10.1016/j.biocel.2017.03.017.

• Badiei A., Gieseg S., Davies S., Othman MI. and Bhatia M. (2016) LPS up-regulates cystathionine y-Lyase gene expression in primary human macrophages via NF-KB/ERK pathway. Inflammation & Allergy - Drug Targets 14(early access online).

• Lindsay A., Bernard A., Davidson SM., Redmond DP., Chiew YS., Pretty C., Chase JG., Shaw GM., Gieseg SP. and Draper N. (2016) Lung injury and respiratory mechanics in rugby union. The Journal of sports medicine and physical fitness 56(4): 450-457.

• Lindsay A., Healy J., Mills W., Lewis J., Gill N., Draper N. and Gieseg SP. (2016) Impact-induced muscle damage and urinary pterins in professional rugby: 7,8-dihydroneopterin oxidation by myoglobin. Scandinavian journal of medicine & science in sports 26(3): 329-337. http://dx.doi.org/10.1111/sms.12436.

• Lindsay A., Othman MI., Prebble H., Davies S. and Gieseg SP. (2016) Repetitive cryotherapy attenuates the in vitro and in vivo mononuclear cell activation response. Experimental physiology 101(7): 851-865. http://dx.doi.org/10.1113/ep085795.

• Badiei A., Gieseg S., Davies S., Othman MI. and Bhatia M. (2015) LPS up-Regulates cystathionine γ-lyase gene expression in primary human macrophages via NF-κB/ERK pathway. Inflammation and Allergy - Drug Targets 14(2): 99-104. http://dx.doi.org/10.2174/1871528114666151201201719.

• Chandrasekaran N., Dimartino S., Janmale T., Gieseg SP. and Fee CJ. (2015) Adsorption of chemically synthesized mussel adhesive peptide sequences containing DOPA on stainless steel. Journal of peptide science : an official publication of the European Peptide Society 21(8): 630-635. http://dx.doi.org/10.1002/psc.2776.

• Janmale T., Genet R., Crone E., Flavall E., Firth C., Pirker J., Roake JA. and Gieseg SP. (2015) Neopterin and 7,8-dihydroneopterin are generated within atherosclerotic plaques. Pteridines 26(3): 93-103. http://dx.doi.org/10.1515/pterid-2015-0004.

• Katouah H., Chen A., Othman I. and Gieseg SP. (2015) Oxidised low density lipoprotein causes human macrophage cell death through oxidant generation and inhibition of key catabolic enzymes. The international journal of biochemistry & cell biology 67: 34-42. http://dx.doi.org/10.1016/j.biocel.2015.08.001.

• Lindsay A., Carr S., Draper N. and Gieseg SP. (2015) Urinary myoglobin quantification by high-performance liquid chromatography: An alternative measurement for exercise-induced muscle damage. Analytical biochemistry 491: 37-42. http://dx.doi.org/10.1016/j.ab.2015.09.001.

• Lindsay A., Carr S., Othman MI., Marks E., Davies S., Petersen C., Draper N. and Gieseg SP. (2015) The physiological and mononuclear cell activation response to cryotherapy following a mixed martial arts contest: a pilot study. Pteridines 26(4): 143-151. http://dx.doi.org/10.1515/pterid-2015-0010.

• Lindsay A., Draper N., Lewis J., Gieseg SP. and Gill N. (2015) Positional demands of professional rugby. European journal of sport science 15(6): 480-487. http://dx.doi.org/10.1080/17461391.2015.1025858.

• Lindsay A., Lewis J., Gill N., Gieseg SP. and Draper N. (2015) Effect of varied recovery interventions on markers of psychophysiological stress in professional rugby union. European journal of sport science 15(6): 543-549. http://dx.doi.org/10.1080/17461391.2015.1029982.

• Lindsay A., Lewis J., Gill N., Gieseg SP. and Draper N. (2015) Immunity, inflammatory and psychophysiological stress response during a competition of professional rugby union. Pteridines 26(4): 153-160. http://dx.doi.org/10.1515/pterid-2015-0012.

• Lindsay A., Lewis J., Scarrott C., Draper N. and Gieseg SP. (2015) Changes in acute biochemical markers of inflammatory and structural stress in rugby union. Journal of sports sciences 33(9): 882-891. http://dx.doi.org/10.1080/02640414.2014.971047.

• Lindsay A., Lewis JG., Scarrott C., Gill N., Gieseg SP. and Draper N. (2015) Assessing the Effectiveness of Selected Biomarkers in the Acute and Cumulative Physiological Stress Response in Professional Rugby Union Through Non-invasive Assessment. International journal of sports medicine 36(6): 446-454. http://dx.doi.org/10.1055/s-0034-1398528.

• Aamir R., Chernoglazov A., Bateman CJ., Butler APH., Butler PH., Anderson NG., Bell ST., Panta RK., Healy JL. and Mohr JL. (2014) MARS spectral molecular imaging of lamb tissue: Data collection and image analysis. Journal of Instrumentation 9(2) http://dx.doi.org/10.1088/1748-0221/9/02/P02005.

• Kader T., Porteous CM., Williams MJA., Gieseg SP. and McCormick SPA. (2014) Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice. Atherosclerosis 237(2): 725-733. http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.101.

• Lindsay A., Janmale T., Draper N. and Gieseg SP. (2014) Measurement of changes in urinary neopterin and total neopterin in body builders using SCX HPLC. Pteridines 25(2): 53-62. http://dx.doi.org/10.1515/pteridines-2014-0003.

• Rajendran K., Walsh MF., de Ruiter NJA., Chernoglazov AI., Panta RK., Butler APH., Butler PH., Bell ST., Anderson NG. and Woodfield TBF. (2014) Reducing beam hardening effects and metal artefacts using Medipix3RX: With applications from biomaterial science. Journal of Instrumentation 9: 1-11. http://dx.doi.org/10.1088/1748-0221/9/03/P03015.

• Hoover SER., Ladley JJ., Shchepetkina AA., Tisch M., Gieseg SP. and Tylianakis JM. (2012) Warming, CO2, and nitrogen deposition interactively affect a plant-pollinator mutualism. Ecology Letters 15(3): 227-234. http://dx.doi.org/10.1111/j.1461-0248.2011.01729.x.

• Ronaldson JP., Zainon R., Scott NJA., Gieseg SP., Butler AP., Butler PH. and Anderson NG. (2012) Toward quantifying the composition of soft issues by spectral CT with Medipix3. Medical physics 39(11): 6847-6857. http://dx.doi.org/10.1118/1.4760773.

• Ronaldson JP., Zainon R., Scott NJA., Gieseg SP., Butler AP., Butler PH. and Anderson NG. (2012) Toward quantifying the composition of soft tissues by spectral CT with Medipix3. Medical Physics 39(1): 6847-6857. http://dx.doi.org/10.1118/1.4760773.

• Rutherford LD. and Gieseg SP. (2012) 7-Ketocholesterol is not cytotoxic to U937 cells when incorporated into acetylated low density lipoprotein. Lipids 47(3): 239-247. http://dx.doi.org/10.1007/s11745-011-3634-1.

• Tuckey NPL., Janssen GJA., Forster ME. and Gieseg SP. (2012) In vitro perfused chinook salmon (Oncorhynchus tshawytscha) tails: a potential model for studying post-harvest tissue chemistry and metabolism in valuable fish tissues. Journal of Aquatic Food Product Technology 21(2): 156-167. http://dx.doi.org/10.1080/10498850.2011.589023.

• Yang Y-TT., Whiteman M. and Gieseg SP. (2012) HOCl causes necrotic cell death in human monocyte derived macrophages through calcium dependent calpain activation. Biochimica et biophysica acta 1823(2): 420-429. http://dx.doi.org/10.1016/j.bbamcr.2011.09.019.

• Yang Y-TT., Whiteman M. and Gieseg SP. (2012) Intracellular glutathione protects human monocyte-derived macrophages from hypochlorite damage. Life sciences 90(17-18): 682-688. http://dx.doi.org/10.1016/j.lfs.2012.03.002.

• Zainon R., Ronaldson JP., Janmale T., Scott NJ., Buckenham TM., Butler APH., Butler PH., Doesburg RM., Gieseg SP. and Roake JA. (2012) Spectral CT of carotid atherosclerotic plaque: comparison with histology. European radiology 22(12): 2581-2588. http://dx.doi.org/10.1007/s00330-012-2538-7.

• Gieseg SP., Amit Z., Yang Y-T., Shchepetkina A. and Katouah H. (2010) Oxidant production, oxLDL uptake, and CD36 levels in human monocyte-derived macrophages are downregulated by the macrophage-generated antioxidant 7,8-dihydroneopterin. Antioxidants & redox signaling 13(10): 1525-1534. http://dx.doi.org/10.1089/ars.2009.3065.

• Tuckey NPL., Forster ME. and Gieseg SP. (2010) Effects of rested harvesting on muscle metabolite concentrations and K-values in Chinook salmon (Oncorhynchus tshawytscha) fillets during storage at 15ºC. Journal of food science 75(5): C459-C464. http://dx.doi.org/10.1111/j.1750-3841.2010.01648.x.

• Gieseg SP., Leake DS., Flavall EM., Amit Z., Reid L. and Yang YT. (2009) Macrophage antioxidant protection within atherosclerotic plaques. Frontiers in Bioscience 14: 1230-1246. http://dx.doi.org/10.2741/3305.

• Tuckey NPL., Forster ME. and Gieseg SP. (2009) Lipid oxidation is inhibited by isoeugenol exposure in Chinook salmon (Oncorhynchus tshawytscha) fillets during storage at 15 degree C. Journal of food science 74(4): C333-C338. http://dx.doi.org/10.1111/j.1750-3841.2009.01135.x.

• Firth CA., Crone EM., Flavall EA., Roake JA. and Gieseg SP. (2008) Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783(6): 1095-1101. http://dx.doi.org/10.1016/j.bbamcr.2008.02.010.

• Firth CA., Laing AD., Baird SK., Pearson J. and Gieseg SP. (2008) Inflammatory sites as a source of plasma neopterin: measurement of high levels of neopterin and markers of oxidative stress in pus drained from human abscesses. Clinical biochemistry 41(13): 1078-1083. http://dx.doi.org/10.1016/j.clinbiochem.2008.06.008.

• Flavall EA., Crone EM., Moore GA. and Gieseg SP. (2008) Dissociation of neopterin and 7,8-dihydroneopterin from plasma components before HPLC analysis. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 863(1): 167-171. http://dx.doi.org/10.1016/j.jchromb.2007.12.019.

• Gieseg SP., Crone EM., Flavall EA. and Amit Z. (2008) Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. British journal of pharmacology 153(4): 627-635. http://dx.doi.org/10.1038/sj.bjp.0707408.

• Firth CA. and Gieseg SP. (2007) Redistribution of metal ions to control low density lipoprotein oxidation in Ham's F10 medium. Free radical research 41(10): 1109-1115. http://dx.doi.org/10.1080/10715760701570099.

• Firth CA., Yang Y-T. and Gieseg SP. (2007) Lipid oxidation predominates over protein hydroperoxide formation in human monocyte-derived macrophages exposed to aqueous peroxyl radicals. Free radical research 41(7): 839-848. http://dx.doi.org/10.1080/10715760701416442.

• Kappler M., Gerry AB., Brown E., Reid L., Leake DS. and Gieseg SP. (2007) Aqueous peroxyl radical exposure to THP-1 cells causes glutathione loss followed by protein oxidation and cell death without increased caspase-3 activity. Biochimica et Biophysica Acta (BBA) - Molecular Cell 1773(6): 945-953. http://dx.doi.org/10.1016/j.bbamcr.2007.04.001.

• Allen VJ., Marsden ID., Ragg NLC. and Gieseg SP. (2006) The effects of tactile stimulants on feeding, growth, behaviour and meat quality of cultured Blackfoot abalone, Haliotis iris. Aquaculture 257(1-4): 294-308. http://dx.doi.org/10.1016/j.aquaculture.2006.02.070.

• Baird SK., Reid L., Hampton MB. and Gieseg SP. (2005) OxLDL induced cell death is inhibited by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but not THP-1 cells. Biochimica et biophysica acta 1745(3): 361-369. http://dx.doi.org/10.1016/j.bbamcr.2005.07.001.

• Baird SK., Hampton MB. and Gieseg SP. (2004) Oxidised LDL triggers phosphatidylserine exposure in human monocyte cell lines by both caspase-dependent and -independent mechanisms. FEBS letters 578(1-2): 169-174. http://dx.doi.org/10.1016/j.febslet.2004.11.007.

• Gieseg S. (2003) ... In New Zealand, too ... [3]. Scientist 17(1): 20.

• Gieseg SP. and Cato S. (2003) Inhibition of cell mediated low-density lipoprotein oxidation by the macrophage synthesised pterin, 7,8 dihydroneopterin. Redox report : communications in free radical research 8(2): 113-115. http://dx.doi.org/10.1179/135100003125001396.

• Gieseg SP., Pearson J. and Firth CA. (2003) Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. Free radical research 37(9): 983-991. http://dx.doi.org/10.1080/10715760310001603612.

• Platt AA. and Gieseg SP. (2003) Inhibition of protein hydroperoxide formation by protein thiols. Redox Report 8(2): 81-86. 10.1179/135100003125001288.

• Platt AA. and Gieseg SP. (2003) Protein thiol inhibited protein hydroperoxide formation. Redox Report 8: 81-86.

• Shand B., Strey C., Scott R., Morrison Z. and Gieseg S. (2003) Pilot study on the clinical and haemodynamic effects of dietary supplementation with Enzogenol, a flavonoid extract of pine bark. Phytotherapy Research 17: 490-494.

• Shand B., Strey C., Scott R., Morrison Z. and Gieseg S. (2003) Pilot study on the clinical effects of dietary supplementation with Enzogenol, a flavonoid extract of pine bark and vitamin C.. Phytother Res 17(5): 490-494. http://dx.doi.org/10.1002/ptr.1181.

• Sutherland WHF., Gieseg SP., Walker RJ., de Jong SA., Firth CA. and Scott N. (2003) Serum protein bound 3,4-dihydroxyphenolalanine and related products of protein oxidation in chronic renal failure. Renal failure 25(6): 997-1009. http://dx.doi.org/10.1081/jdi-120026035.

• Duggan S., Rait C., Platt A. and Gieseg S. (2002) Protein and thiol oxidation in cells exposed to peroxyl radicals is inhibited by the macrophage synthesised pterin 7,8-dihydroneopterin.. Biochim Biophys Acta 1591(1-3): 139-145.

• Duggan S., Rait C., Platt A. and Gieseg S. (2002) Protein and thiol oxidation in cells exposed to peroxyl radicals is inhibited by the macrophage sythesised pterin 7, 8-dihydroneopterin.. Biochim Biophys Acta 19 August 2002: 1591(1--3): 139-145.

• Duggan S., Rait C., Gebicki JM. and Gieseg SP. (2001) Inhibition of protein oxidation by the macrophage-synthesised antioxidant 7, 8-dihydroneopterin. Redox report : communications in free radical research 6(3): 188-190. http://dx.doi.org/10.1179/135100001101536175.

• Gieseg SP., Maghzal G. and Glubb D. (2001) Protection of erythrocytes by the macrophage synthesized antioxidant 7, 8 dihydroneopterin. Free radical research 34(2): 123-136. http://dx.doi.org/10.1080/10715760100300121.

• Gieseg SP., Whybrow J., Glubb D. and Rait C. (2001) Protection of U937 cells from free radical damage by the macrophage synthesized antioxidant 7, 8 dihydroneopterin. Free radical research 35(3): 311-318. http://dx.doi.org/10.1080/10715760100300841.

• Gebicki JM., Collins J., Gay C., Duggan S. and Gieseg S. (2000) The dissection of oxidative changes in human blood serum and U937 cells exposed to free radicals. Redox Report 5: 55-56.

• Gieseg SP., Cuddihy S., Hill JV. and Davison W. (2000) A comparison of plasma vitamin C and E levels in two Antarctic and two temperate water fish species. Comp Biochem Physiol B Biochem Mol Biol 125(3): 371-378.

• Gieseg SP., Duggan S. and Gebicki JM. (2000) Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals. Biochemistry Journal 350: 215-218.

• Gieseg SP., Maghzal G. and Glubb D. (2000) Inhibition of haemolysis by the macrophage synthesized antioxidant, 7, 8-dihydroneopterin. Redox Report 5(2/3): 98-100.

• Gieseg SP., Maghzal G. and Glubb D. (2000) Inhibition of haemolysis by the macrophage synthesized antioxidant, 7,8-dihydroneopterin.. Redox Rep 5(2-3): 98-100. http://dx.doi.org/10.1179/135100000101535645.

• Gieseg S. (1999) Reducing Free Radicals. New Zealand Science Monthly July 1999: 6-8.

• Forster ME., Davison W., Axelsson M., Sundin L., Franklin CE. and Gieseg S. (1998) Catecholamine release in heat-stressed Antarctic fish causes proton extrusion by the red cells. Journal of Comparative Physiology B: Biochemical, Systems, and Environmental Physiology 168(5): 345-352. http://dx.doi.org/10.1007/s003600050153.

• Ziouzenkova O., Gieseg SP., Ramos P. and Esterbauer H. (1996) Factors affecting resistance of low density lipoproteins to oxidation.. Lipids 31 Suppl: S71-S76.

• Gieseg SP., Reibnegger G., Wachter H. and Esterbauer H. (1995) 7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant. Free radical research 23(2): 123-136. http://dx.doi.org/10.3109/10715769509064027.

• Ramos P., Gieseg SP., Schuster B. and Esterbauer H. (1995) Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. Journal of lipid research 36(10): 2113-2128.

• Gieseg SP. and Esterbauer H. (1994) Low density lipoprotein is saturable by pro-oxidant copper. FEBS letters 343(3): 188-194. http://dx.doi.org/10.1016/0014-5793(94)80553-9.

• O'Connell AM., Gieseg SP. and Stanley KK. (1994) Hypochlorite oxidation causes cross-linking of Lp(a).. Biochim Biophys Acta 1225(2): 180-186.

• Dean RT., Gieseg SP. and Davies MJ. (1993) Reactive species and their accumulation on radical-damaged proteins. Trends in Biological Science 18(11): 437-441.

• Gieseg SP., Simpson JA., Charlton T., Duncan M. and Dean RT. (1993) Protein bound DOPA is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32(18): 4780-4786.

• Gieseg SP., Simpson JA., Charlton TS., Duncan MW. and Dean RT. (1993) Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins.. Biochemistry 32(18): 4780-4786.

• O'Connell A., Gieseg SP. and Stanley KK. (1993) Hypochlorite oxidation of Lp(a) and LDL causes cross-linking into a highly atherogenic form. Biochemica et Biophysica Acta 1225: 180-186.

• Simpson JA., Gieseg SP. and Dean RT. (1993) Free radical and enzymatic mechanisms for the generation of protein bound reducing moieties.. Biochim Biophys Acta 1156(2): 190-196.

• Simpson JA., Gieseg SP. and Dean RT. (1993) Radical and enzymatic mechanisms for the generation of protein bound reducing moieties. Biochemica et Biophysica Acta 1156: 190-196.

• Dean RT., Gebicki J., Gieseg SP., Grant AJ. and Simpson JA. (1992) Hypothesis: A damaging role in aging for reactive protein oxidation products? Mutation Research 275: 387-393.

• Gieseg SP., Forrester IT. and Carne A. (1992) The purification of ovine pancreatic lipase that is free of colipase using an improved delipidation method. Pancreas 7(1): 45-51.

• Jessup W., Mohr D., Gieseg SP., Dean RT. and Stocker R. (1992) The participation of nitric oxide in cell-free and macrophage-mediated oxidation of low-density lipoprotein. Biochimica et biophysica acta 1180(1): 73-82. http://dx.doi.org/10.1016/0925-4439(92)90029-m.

• Simpson J., Narita S., Gieseg SP., Gebicki S., Gebicki J. and Dean RT. (1992) Long-lived reactive species on free radical-damaged proteins. Biochemical Journal 282: 621-624.

• Gieseg SP., Grigor MR. and Carne A. (1991) Sequence and immunological characterization of ovine pancreatic lipase. Biochemistry international 23(5): 949-957.

• Trotman CNA., Gieseg SP., Pirie RS. and Tate WP. (1987) Abnormal development in Artemia: Defective emergence of the prenauplius with bicarbonate deficiency. Journal of Experimental Zoology 243: 173-346.

• TROTMAN CNA., GIESEG SP., PIRIE RS. and TATE WP. (1987) ABNORMAL-DEVELOPMENT IN ARTEMIA - DEFECTIVE EMERGENCE OF THE PRENAUPLIUS WITH BICARBONATE DEFICIENCY. JOURNAL OF EXPERIMENTAL ZOOLOGY 243(2): 225-232. http://dx.doi.org/10.1002/jez.1402430208.

Conference Contributions - Published

• Gieseg SP., Prebble H., Cross S. and Hock B. (2018) THE MACROPHAGE INFLAMMATION MARKER NEOPTERIN IS GENERATED BY THE REACTION WITH SUPEROXIDE RELEASED DURING OXLDL MEDIATED CELL DEATH. In ATHEROSCLEROSIS SUPPLEMENTS 32: 124-124. http://dx.doi.org/10.1016/j.atherosclerosissup.2018.04.380.

• Gieseg SP., Prebble H., Searle E. and Butler A. (2018) SPECTRAL X-RAY IMAGING OF ATHEROSCLEROTIC PLAQUE BY MARS-SCANNING. In ATHEROSCLEROSIS SUPPLEMENTS 32: 6-7. http://dx.doi.org/10.1016/j.atherosclerosissup.2018.04.020.

• Petersen CJ., Lindsay A., Blackwell G., Ferguson H., Parker G. and Gieseg S. (2016) Quantifying energy system capacity changes in cycling from 7 days ischemic leg preconditioning. Vienna, Austria: 21st Annual Congress of the European Congress of Sport Science (ECSS), 6-9 Jul 2016. In Book of Abstracts: 511.

• Palmer BR., Marks ECA., Wilkinson TM., Pemberton CJ., Gieseg SP., Frampton CMA., Skelton L., Doughty RN., Cameron VA. and Richards AM. (2014) Biomarkers from the VEGF system as predictors of acute heart failure admission in established coronary heart disease. In EUROPEAN JOURNAL OF HEART FAILURE 16: 213-213.

• Zainon R., Butler PH., Gieseg SP., Janmale T., Ronaldson JP., Anderson NG., Butler APH., Scott NJ. and IEEE. (2014) High Resolution Spectral Micro-CT Imaging of Atherosclerotic Plaque. In 2014 IEEE REGION 10 SYMPOSIUM: 568-571.

• Othman MI. and Gieseg SP. (2013) THE ROLE OF CALCIUM IN OXLDL MEDIATED CELL DEATH IN HUMAN MONOCYTES: POSSIBLE MECHANISM OF ATHEROSCLEROTIC PLAQUE PROGRESSION. Beijing, PEOPLES R CHINA: 24th Great Wall International Congress of Cardiology / Asia Pacific Heart Congress / International Congress of Cardiovascular Prevention and Rehabilitation, 10-13 Oct 2013. In HEART 99: E89-E90. http://dx.doi.org/10.1136/heartjnl-2013-304613.242.

• Gieseg SP., Reid L., Baird SK. and Hampton MB. (2005) Inhibition of caspase independent apoptosis in human derived macrophages. West Midlands, England, Unit: Annual Meeting: Society for Free Radical Research - Europe 2005 "Reactive Oxygen Species and Disease Mechanisms", 8 Jul 2005. In Free Radical Research 39(S1).

Chapters

• Azzani L., Rasmussen JL., Gieseg SP. and Briskie JV. (2016) An experimental test of the effect of diet on preen wax composition in New Zealand silvereyes (Zosterops lateralis). In Schulte BA; Goodwin TE; Ferkin MH (Ed.), Chemical Signals in Vertebrates: 511-525. Switzerland: Springer International Publishing.

• Azzani L., Rasmussen JL., Gieseg SP. and Briskie JV. (2016) An experimental test of the effect of diet on preen wax composition in New Zealand silvereyes (Zosterops lateralis). In Shulte BA (Ed.), Chemical Signals in Vertebrates 13: 511-525. Cham, Switzerland: Springer International Publishing.

• Gieseg SP., Crone E. and Amit Z. (2010) Oxidized Low Density Lipoprotein Cytotoxicity and Vascular Disease. In O'Brien PJ; Bruce WR (Ed.), Endogenous Toxins: Targets for Disease Treatment and Prevention: 619-645. Weinheim: Wiley-VCH Verlag GmbH & Co. http://dx.doi.org/10.1002/9783527628100.ch25.

• Gieseg SP. (1998) Free Radicals - more than a revolution. In Duncan DK (Ed.), Fighting Free Radicals, The Enzogenol Story: 44-54. Christchurch: The Pacific Scientific Press.

• Dean R., Fu S., Gieseg S. and Armstrong SG. (1996) Protein hydroperoxides, protein hydroxides and protein bound DOPA. In Punchard NA; Kelly FJ (Ed.), Free Radicals A practical Approach. The Practical Approach Series: 171-182. UK: Oxford University Press.

• Esterbauer H., Gieseg S., Giessauf A., Ziouzenkova O. and Ramous P. (1995) Free Radicals and Oxidative Modification of LDL. Role of natural Antioxidants. In Woodford FP; Davignon J; Sniderman A (Ed.), Atherosclerosis X: 203-208. Netherlands: Elsevier.

• Esterbauer H., Gieseg S., Giessauf A., Ziouzenkova O. and Ramous P. (1995) Role of natural antioxidants in inhibiting Cu++ mediated oxidation of LDL. In Bellomo G; Finardi G; Maggi E; Rice-Evans C (Ed.), Free Radicals, Lipoprotein Oxidation and Atherosclerosis: 11-25. London: Riochelieu Press.

• Dean RT., Gieseg SP. and Simpson JA. (1993) Marker or mechanism: Possible pro-oxidant reactions of radical-damaged proteins in aging and atherosclerosis, an age related disease. In Poli G; Albano E; Dianzai U (Ed.), Free Radicals: From Basic Science to Medicine: 175-1284. Boston: Birkhauser Boston: Scientific and Technical Publishing.

• Jessup W., Dean RT., Gieseg SP., Hazell L., Kritharides L., Mander E., Simpson JA. and Stocker R. (1993) Oxidation of lipids and apolipoprotein B in LDL. In Prati G (Ed.), Mechanisms and consequences. Symposium on dietary lipids, antioxidants and the prevention of atherosclerosis. Symposium held in Asolo, Italy december of 1992: 35119-35122. Padova Italy: Cooperative Libratia Editrice dell'Universita di Padova.

• Trotman CNA., Gieseg SP., Pirie RS. and Tate W. (1989) Development abnormalities related to bicarbonate ion status during emergence of Artemia. In Warner AH; MacRae TH; Bagshaw JC (Ed.), Cellular and Molecular Biology of Artemia Development: 17-28. New York: Plenum Press.

Conference Contributions - Other

• Gieseg SP. (2016) Macrophage NADPH oxidase (NOX2) generates plasma neopterin in CVD, (speaker). Hotel Grand Chancellor Hobart, Australia: Joint with AAS, AVBS & HBPRCA, 7-10 Dec 2016.

• Gieseg SP., Lindsay A., Draper N., Lewis JG., Carr S., Cross S. and Petersen CJ. (2016) Neopterin generation during inflammation and oxidative stress following high impact sport. Innsbruck, Austria: 35th International Winter-Workshop: Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics, 23-26 Feb 2016.

• Gieseg SP., Roake JA., Chen A., Katouah H., Cross SP., Othman MI. and Prebble H. (2016) Neopterin generation during inflammation and oxidative stress following high impact sport. Inssbruck, Austria: 35th International Winter-Workshop Clinical, Chemical and Biochemical Aspects of pteridines and related topics, 23-26 Feb 2016.

• Lindsay A., Healy J., Mills W., Lewis J., Gill N., Draper N. and Gieseg SP. (2016) 7,8-Dihydroneopterin oxidation to neopterin in macrophages and atherosclerotic plaques. Medizinische Universitat, Innsbruck, Austria: 35th International Winter-Workshop Clinical, Chemical and Biochemical Aspects of pteridines and related topics titled, 23-26 Feb 2016.

• Katouah H., Chen A., Othman I. and Gieseg SP. (2015) Oxidant and neopterin generation within macrophages exposed to OxLDL. Western Australia Maritime Museum, Perth, Australia: 2015 Australian Atherosclerosis Society Annual Meeting, 21-23 Oct 2015.

• Lindsay A., Lewis J., Gill N., Gieseg SP. and Draper N. (2015) Multienergy X-ray-CT identification of lipid core and calcium mineralisation in excised carotid plaques. Western Australia Maritime Museum, Perth, Australia: 2015 Australian Atherosclerosis Society Annual Meeting, 21-23 Oct 2015.

• Lindsay A., Lewis JG., Scarrott C., Gill N., Gieseg SP. and Draper N. (2015) Is plasma neopterin the product of intracellular oxidant scavenging by 7,8-dihydroneopterin? Otago University at Christchurch, New Zealand: Joint Society for Free Radical Research Australasia and Free Radical Research Japan, 7-10 Dec 2015.

• Gieseg SP. (2014) Neopterin is a direct marker of y-interferon activation of macrophages and oxidative stress within human atherosclerotic plaque. Adelaide, Australia: Australian Atherosclerosis Society Annual Meeting with State of the Heart 2014, 26-28 Nov 2014.

• Gieseg SP. (2014) NOX/p47phox activation and oxidative stress in acute macrophage necrosis. Melbourne, Australia: Society of Free Radical Research Australasia Biannual Conference, 3-6 Dec 2014.

• Gieseg SP., Chen A., Katouah H., Shchepetkina A. and Othman I. (2014) NOX/p47phox activation and oxidative stress in acute macrophage necrosis. The Adelaide Convention Centre. Adelaide, Australia: State of the Heart 2014, 26-28 Nov 2014.

• Gieseg SP., Janmale T., Panta R., Aamir R., Healy J., de Ruiter NJA., Bateman CJ., Bell ST., Walsh MF. and Chernoglazov A. (2014) Imaging of advanced atherosclerotic plaque by high resolution, multi-energy X-ray computer tomography. Melbourne, AUSTRALIA: 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), 5-7 Dec 2013.

• Marks E., Palmer B. and Gieseg SP. (2014) sFLT-1, a robust biomarker of diagnosis and prognosis of heart disease. The Adelaide Convention Centre, Adelaide, Australia.: State of the Heart 2014, 26-28 Nov 2014.

• Gieseg SP. (2013) Acute cell death by hyperactivation of human macrophages by oxLDL. Queenstown, New Zealand: Queenstown Research Week: Heart Theme Meeting, 25-25 Aug 2013.

• Gieseg SP. (2013) Imaging of advanced atherosclerotic plaque by high resolution, multi-energy X-ray computer tomography. Geneva, Switzerland: 2nd Workshop on Medical Applications of Spectroscopic X-ray Detectors, 22-25 Apr 2013.

• Lindsay A., Lewis J., Chase G., Scarrott C., Shaw G., Gieseg S. and Draper N. (2013) The effect of acute exercise on levels of stress in rugby union and competitive body building. Christchurch, New Zealand: Sport and Exercise Science New Zealand Annual Conference, 29-30 Nov 2013.

• Gieseg SP. (2012) Imaging of advanced atherosclerotic plaque by high resolution, multi-energy X-ray computer tomography: Identification of iron and calcium deposition. Sydney, Australia: XVI International Symposium on Atherosclerosis (ISA), 25-29 Mar 2012.

• Gieseg SP. (2012) Mechanisms and inhibitors of macrophage cell death within advance atherosclerotic plaques. Faculty of Medical and Health Sciences, University of Auckland Grafton Campus, New Zealand: Auckland 2012 Cardiac Mechanisms Workshop, 18-19 Jun 2012.

• Gieseg SP., Shchepetkina A., Chen A. and Katouah H. (2012) Scavenger Receptor CD36 does not initiate oxLDL induced macrophage cell death. Sydney, Australia: XVI International Symposium on Atherosclerosis (ISA), 25-29 Mar 2012.

• Burgess L. and Gieseg SP. (2011) Cytotoxicity of HOCl oxidised LDL in human monocyte derived macrophages. Queenstown, New Zealand: Queenstown Molecular Biology: Heart Meeting, 25-25 Aug 2011.

• Gieseg SP. (2011) Dihydroneopterin and atherosclerosis: Marker or bystander? Queenstown, New Zealand: Queenstown Molecular Biology: Heart Meeting, 29-29 Aug 2011.

• Gieseg SP. (2011) Inhibition of oxidised low density lipoprotein initiated oxidative stress by 7,80Dihydroneopterin. St. Christoph, Arlberg, Austria: 30th International Winter-Workshop on Clinical, Chemical and Biochemical Aspects if Pteridines, 13-20 Mar 2011.

• Gieseg SP. (2011) OxLDL induced macrophage cell death is not dependent on scavenger receptor CD36. Adelaide, Australia: Australian Atherosclerosis Society Annual Meeting, 18-21 Oct 2011.

• Gieseg SP. (2010) Cytotoxicity of oxLDL: how important is oxysterol formation? Akaroa, New Zealand: 19th Annual Conference of the Society for Free Radical Research of Australasian, 1-1 Nov 2010.

• Gieseg SP., Chen A. and Shchepetkina AA. (2010) Inhibition of Oxidised Low Density Lipoprotein Initiated Oxidative Stress by 7,8-dihydroneopterin. St Christoph, Austria: 30th International Winter-Workshop on Clinical, Chemical and Biochemical Aspects of Pteridines, 13-20 Mar 2011.

• Rutherford LD. and Gieseg SP. (2010) Toxicity of oxidised cholesterol as a mechanism of cardiovascular disease. Christchurch, New Zealand: Health Research Society of Canterbury Seminar Series, 26-26 Mar 2010.

• Zainon R., Cook N., Butler AP., Gieseg SP., Anderson NG., Buckenham TM., Shelkov G., Tlustos L., Roake JA. and Butler P. (2010) High resolution multi-energy CT imaging of atherosclerotic plaque. Christchurch, New Zealand: Health Research Society of Canterbury Seminar Series, 16-16 Jul 2010.

• Gieseg S. (2009) CD36 Down Regulation and Oxidant Scavenging By Reduced Neopterin Inhibits OxLDL Mediated Macrophage Cell Death. Melbourne, Australia: 35th Annual Scientific Meeting of the Australian Atherosclerosis Society, 13-16 Oct 2009.

• Gieseg S. (2009) High Resolution Multi-Energy CT Imaging Of Atherosclerotic Plaque: The Future Of X-Ray Ct Imaging. Melbourne, Australia: 35th Annual Scientific Meeting of the Australian Atherosclerosis Society, 13-16 Oct 2009.

• Gieseg SP. (2009) Macrophage necrosis due to excessive oxidant production is triggered by oxidised low-density lipoprotein. Christchurch, New Zealand: ComBio 2009, 6-10 Dec 2009.

• Gieseg SP., Amit Z., Yang T. and Katouah H. (2009) Inhibition of OxLDL-mediated macrophage necrosis by down regulation of oxLDL uptake, CD36 expression and intracellular oxidant production by 7,8-dihydroneopterin. St Christoph, Austria: 28th International Winter-Workshop Clinical, Chemical, & Biochemical Aspects of Pteridines, 1-8 Mar 2009.

• Gieseg SP., Amit Z., Yang T., Katouah H. and Shchepetkina A. (2009) CD36 down regulation and oxidant scavenging by reduced neopterin inhibits oxLDL mediated macrophage cell death. Sydney, Australia: 5th Joint Meeting of the Societies for Free Radical Research Australasia and Japan, 1-4 Dec 2009.

• Gieseg SP., Baird SK., Crone E., Firth CA., Flavall E., Genet R., Laing AD., Pearson J. and Roake J. (2009) Distribution of Biomarkers of Oxidation and Macrophage Activation in Human pus and Atherosclerotic Plaques. St Christoph, Austria: 28th International Winter-Workshop Clinical, Chemical, & Biochemical Aspects of Pteridines, 1-8 Mar 2009.

• Shchepetkina AA., Janmale T. and Gieseg SP. (2009) 7,8-Dihydroneopterin down-regulates CD36, a macrophage scavenger receptor for oxLDL. Christchurch, New Zealand: ComBio 2009, 6-10 Dec 2009.

• Gieseg S. (2008) Distribution of biomarkers of oxidation and macrophage activation in human atherosclerotic plaques. Millennium Hotel, Queenstown, New Zealand: New Zealand Society for Medical Sciences, Medical Science Congress, 26-26 Nov 2008.

• Gieseg S. (2008) Macrophage secreted pterin, 7,8 Dihydroneopterin, inhibits oxidised low density lipoprotein induced cell death. Otago University, Dunedin, New Zealand: Chemistry and the Biosphere Conference. Combined meeting of the NZ Soc. for Biochem & Mol. Biol. and the NZ Inst. Chem. and NZ Soc. Plant Biol., 1-1 Dec 2008.

• Gieseg SP., Amit Z., Yang T. and Katouah H. (2008) OxLDL uptake, CD36 levels, intracellular superoxide production levels is down regulated by the macrophage secreted antioxidant 7,8-dihydroneopterin. Sydney, Australia: Australian Atherosclerosis Society Annual Scientific Meeting, 1 Jan 2008.

• Katouah HA. and Gieseg SP. (2008) Failure of cell metabolism as mechanism of atherosclerosis. Christchurch, New Zealand: Health Research Society of Canterbury Conference, 25-25 Aug 2007.

• Flavall E., Moore G. and Gieseg S. (2007) Dissociation of neopterin and 7,8-dihydroneopterin from plasma proteins during analysis. Christchurch, New Zealand: Health Research Society of Canterbury (HRSC) AGM and Scientific Meeting, 21-21 Mar 2007.

• Gieseg SP. (2007) The macrophage derived marker of inflammation 7,8-dihydroneopterin, preventions oxldl induced macrophage cell death. Queenstown, New Zealand: Medical Sciences Congress 2007 (MEDSCINZ 2007), 27-30 Nov 2007.

• Gieseg SP. and Amit Z. (2007) OxLDL induced cell death is inhibited by the macrophage antioxidant 7,8-dihydroneopterin. Bristol, UK: 4th European Meeting on Vascular Biology and Medicine, 1 Jan 2007.

• Amit Z. and Gieseg SP. (2006) Formation of foam cell from human monocyte-derived macrophages in the absence of modified low density lipoprotein. Christchurch, New Zealand: Health Research Society of Canterbury's AGM and Scientific Meeting, 14-14 Jun 2006.

• Flavall E., Moore G. and Gieseg S. (2006) Dissociation of neopterin and 7,8-dihydroneopterin from plasma proteins during analysis. University of Western Australia, Perth, Australia: 15th Annual Conference of the Society for Free Radical Research of Australasia, 1-4 Dec 2006.

• Gieseg S. (2006) Inhibition of peroxyl radical mediated plasma protein hydroperoxide formation. University of Western Australia, Perth, Australia: 15th Annual Conference of the Society for Free Radical Research of Australasian, 1-4 Dec 2006.

• Gieseg SP., Kappler M., Gerry A., Baird S. and Leake D. (2006) Caspase Activation Failure in Human THP-1 Monocyte-like Cells. Queenstown, New Zealand: Annual Queenstown Molecular Biology Meeting, 29 Aug-1 Sep 2006.

• Tuckey N., Gieseg SP. and Forster M. (2006) Inhibition of salmon tissue degradation following treatment with the anaesthetic AQUI-S. University of Western Australia, Perth, Australia: 15th Annual Conference of the Society for Free Radical Research of Australasia, 1-4 Dec 2006.

• Tuckey N., Gieseg SP. and Forster M. (2006) Something smells fishy: preserving the nutritional value of aquacultured fish. Christchurch, New Zealand: Health Research Society of Canterbury's AGM and Scientific Meeting, 14-14 Jun 2006.

• Gieseg S. (2005) Caspase Activation Failure In THP-1 Cells During Apoptosis. Griffith University, Brisbane, Australia: combined Societies for Free Radical Research of Japan and Australasian, 1 Dec 2005.

• Gieseg S. (2005) The Apoptosis/Necrosis Axis Maybe Be Determined By Thiol Response In Monocyte Like Cell Lines. Dunedin, New Zealand: combined NZ Biochemistry and Molecular Biology, and NZ Microbiology conference, 1 Nov 2005.

• Gieseg SP., Reid L., Baird S. and Hampton MB. (2005) Inhibition of caspase independent apoptosis in macrophages. Leicester, UK: European Society for Free Radical Research Conference, 1 Jan 2005.

• Reid L. and Gieseg S. (2005) Human macrophages undergo caspase-3 independent apoptosis in response to oxidised low density lipoprotein. Prague, Czech Republic: 75th European atherosclerosis Society Congress, 1 Jan 2005.

• Tuckey N., Forster M. and Gieseg S. (2005) The effects of radical damage and antioxidants on tissue viability and storage properties in Chinook salmon. Griffith University, Brisbane, Australia: Third Joint Meeting of the Society for Free Radical Research, Australasia and Japan, 1 Dec 2005.

• Baird SK., Hampton MB. and Gieseg SP. (2004) Caspase independent but not caspase dependent oxLDL induced apoptosis can be inhibited by a macrophage generated antioxidant. Sydney, Australia: The Australian Health and Medical Research Congress, 1 Jan 2004.

• Firth C. and Gieseg SP. (2004) 7,8-dihydroneopterin's antioxidant activity inhibits macrophage-mediated protein hydroperoxide formation on low density lipoprotein. Christchurch, New Zealand: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2004.

• Firth CA. and Gieseg SP. (2004) The antioxidant activity of 7,8-dihydroneopterin inhibits macrophage-mediated protein hydroperoxide formation on low density lipoprotein. Sydney, Australia: The Australian Health and Medical Research Congress, 1 Jan 2004.

• Gieseg S. (2004) Protein Oxidation in Plasma, Lipoproteins and Macrophages. Christchurch, New Zealand: University of Otago Oxidative Theme meeting, 1 Jan 2004.

• Gieseg S. (2004) Protein oxidation, the forgotten marker of lipoprotein damage. Christchurch, New Zealand: Canterbury Health Science Conference, 1 Jan 2004.

• Gieseg S. (2004) Where in the aqueous phase does AAPH decay to peroxyl radicals? Evidence that AAPH may associate with membrane structure. Christchurch, New Zealand: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2004.

• Kappler M. and Gieseg SP. (2004) Response of THP-1 cells to oxidative damage induced by AAPH. Christchurch, New Zealand: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2004.

• Reid L. and Gieseg SP. (2004) OxLDL induced apoptosis in human macrophages. Sydney, Australia: The Australian Health and Medical Research Congress, 1 Jan 2004.

• Firth C. and Gieseg S. (2003) Protein hydroperoxide formation is inhibited by 7,8-dihydroneopterin during macrophage-mediated oxidation of low density lipoprotein. Seattle, WA, USA: 10th Annual Meeting of the Society for Free Radical Biology and Medicine, 20 Nov 2003.

• Firth CA. and Gieseg SP. (2003) Protein hydroperoxide formation on low density lipoprotein during macropahge mediated oxidation. Woollongong, Australia: Society for Free Radical Research (Australisia), 1 Dec 2003.

• Gieseg S., Firth C. and Pearson J. (2003) Protein hydroperoxides are formed on low-density-lipoprotein during cell mediated oxidation. Seattle, WA, USA: 10th Annual Meeting of the Society for Free Radical Biology and Medicine, 20 Nov 2003.

• Baird S. and Gieseg S. (2002) gamma-interferon stimulated pterin modulation of apoptosis in human macrophages exposed to oxLDL. Paris, France: XIth Meeting of the Society for Free radical Research International. Free Radical Biology & Medicine, 1 Jan 2002.

• Cassidy L. and Gieseg SP. (2002) Identification of labile amino acid residues during peroxyl radical mediated cellular oxidation. Christchurch, New Zealand: Society for Biochemistry and Molecule Biology meeting: Microbes and Molecules, 1 Jan 2002.

• Firth CA. and Gieseg SP. (2002) Macropaghe-mediated oxidation of low density lipoprotein generates protein hydroperoxides. Christchurch, New Zealand: Society for Biochemistry and Molecular Biology meeting: Microbes and Molecules, 1 Jan 2002.

• Firth CA. and Gieseg SP. (2002) Protein hydroperoxide formation on low density lipoprotein during macrophage mediated oxidation. Woollongong, NSW, Australia: Society for Free Radical Research (Australasia), 1 Jan 2002.

• Gieseg S. (2002) Oxidative Damage to Cells Causes the peroxidation of Cellular Proteins. Christchurch, New Zealand: Society for Biochemistry and Molecular Biology Meeting "Microbes and Molecules", 26 Nov 2002.

• Gieseg SP., Cato S., Pearson J. and Baird S. (2002) Pterin production by macrophages inhibits cell mediated LDL oxidation. Perth, Australia: Proceedings of Australian Atherosclerosis Society Meeting., 1 Jan 2002.

• Pearson J., Gieseg SP. and Firth C. (2002) Protein hydroperoxide formation on low density lipoprotein. Christchurch, New Zealand: Society for Biochemistry and Molecular Biology meeting: Microbes and Molecules, 1 Jan 2002.

• Platt A. and Gieseg SP. (2002) Protein thiol groups as peroxyl radical scavengers. Christchurch, New Zealand: Society for Biochemistry and Molecular Biology meeting: Microbes and Molecules, 1 Jan 2002.

• Baird S., Hampton M. and Gieseg S. (2001) OxLDL induced apoptosis of human macrophages. Christchurch Medical School: Proceedings of the Christchurch Medical Research Society, 1 Jan 2001.

• Baird SK. (2001) Pterin modulation of cell redox status in apoptosis in human macrophages exposed to oxLDL. Christchurch, New Zealand: Society for Biochemisty and Molecular Biology Meeting: Microbes and Molecules., 1 Jan 2001.

• Baird SK. and Gieseg SP. (2001) γ-Interferon stimulated pterin modulation of apoptosis in human macrophages exposed to oxLDL and peroxyl radicals. Sydney, Australia: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2001.

• Cato S. and Gieseg SP. (2001) Prevention of low density lipoprotein oxidation by 7, 8-dihydroneopterin. Christchurch Medical School: Christchurch Medical Research Society Meeting, 1 Apr 2001.

• Gieseg S. (2001) Inhibition of Cell Mediated LDL Oxidation by Macrophage Synthesised Pterins. Perth, Australia: Australia Atherosclerosis Society Meeting, 1 Jan 2001.

• Pearson J. and Gieseg SP. (2001) Protein hydroperoxide formation on low density lipoprotein. Sydney, Australia: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2001.

• Platt AA. and Gieseg SP. (2001) Protein thiol groups as peroxiyl radical scavengers. Sydney, Australia: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2001.

• Baird S., Hampton M. and Gieseg SP. (2000) The effect of macrophage antioxidant on oxLDL-oxLDL -induced apoptosis. Wellington, New Zealand: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2000.

• Baird SK., Hampton M. and Gieseg SP. (2000) oxLDL-induced apoptosis of human macropahages. Adelaide, Australia: The Australian Atherosclerosis Society Meeting, 1 Jan 2000.

• Cato S., Baird S. and Gieseg SP. (2000) Effect of the macrophage antioxidant 7,8 dihydroneoptern on cell mediated oxidation and cell death]. Adelaide, Australia: The Australian Atherosclerosis Society meeting, 1 Jan 2000.

• Duggan S. and Gieseg S. (2000) Protection from oxidative damage to U937 cells by 7, 8NP, an endogenous antioxidant. Christchurch, New Zealand: Christchurch Medical Research Society Meeting, 1 Jan 2000.

• Duggan S., Rait C., Gebicki J. and Gieseg SP. (2000) Protection of macrophage proteins from free radical damage. Wellington, New Zealand: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 2000.

• Gieseg S., Glubb D., Magzhal G. and Whybrow J. (2000) Possible role of neopterin release during inflammation. Christchurch, New Zealand: Proceedings of the Christchurch Medical Research Society, 1 Jan 2000.

• Pearson J. and Gieseg SP. (2000) Protein hydroperoxide formation on apoB may be a significant event in the devlopment of atherosclerosis. Christchurch, New Zealand: Christchurch Medical Research Society Meeting, 1 Apr 2000.

• Duggan S. and Gieseg SP. (1999) Protection from oxidative damage to U937 cells by 78MP, an edogenous antioxidant. Sydney, Australia: The Society for Free Radical Research (Australasia) Biannual Conference, 1 Jan 1999.

• Gebicki J., Gay C., Collins J., Gieseg SP. and Duggan S. (1999) Free radical induced oxidation of human blood serum an its prevention. Mumbai, India: International Symposium on Recent Trends in Biomedical Research, 1 Jan 1999.

• Gieseg S. (1999) Protection of the plasma membrane by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Sydney, Australia: Society for Free Radical Research (Australasia) Annual Conference, 1 Jan 1999.

• Gieseg SP. and Baird S. (1998) Comparison of antioxidant assays for flavanoid containing supplements. Washington DC, USA: Oxygen 98, 1 Jan 1998.

• Gieseg SP., Cruz T., Glubb D., Muzghal G. and Whybrow J. (1998) 7,8 dihydroneopterin can protect cells from free radical mediated damage. Washington DC, USA: Oxygen 98, 1 Jan 1998.

• Clark T., Gieseg SP. and Vile G. (1997) Apoptosis: Induction by peroxides. Dunedin, New Zealand: The Society for Free Radical Research (Australasia) Biannual Conference, 1 Jan 1997.

• Cruz T., Whybrow J. and Gieseg SP. (1997) 7,8-Dihydroneopterin protection of cellular membranes. Dunedin, New Zealand: The Society for Free Radical Research (Australasia) Biannual Conference, 1 Jan 1997.

• Cruz T., Whybrow J. and Gieseg SP. (1997) 7,8-Dihydroneopterin protection of lipids. Leura, NSW, Australia: The Australian Atherosclerosis Society meeting, 1 Jan 1997.

• Whybrow J., Glubb D., Cruz T. and Gieseg SP. (1997) 7,8 Dihydroneopterin protection of cellular membranes. Dunedin, New Zealand: The Society for Free Radical Research (Australasia) Biannual Conference, 1 Jan 1997.

• Gieseg S. (1996) Antioxidants and oxidation assays, Fact and Artifact. Auckland, New Zealand: New Zealand Atherosclerosis Conference, 1 Jan 1996.

• Gieseg S. and Esterbauer H. (1996) Why is 7,8 dihydroneopterin released by γ-interferon stimulated macrophages? Barcelona, Spain: SFRR International conference, 1 Jan 1996.

• Gieseg SP., Reibnegger G., Wachter H. and Esterbauer H. (1996) What is the Role of Neopterin Release by Monocytes during Inflammation? Christchurch, New Zealand: Proceedings of Christchurch Medical Research Society, 1 Jan 1996.

• Gieseg S. (1995) The role of neopterin release by monocytes during inflammation. Christchurch, New Zealand: Australian and New Zealand Society for Comparative Physiology and Biochemistry, 1 Jan 1995.

• Gieseg S. (1995) What is the role of Neopterin release by monocytes during inflammation. Christchurch, New Zealand: Christchurch Medical Research Society Scientific Meeting, 1 Jan 1995.

• Gieseg SP., Reibnegger G., Wachter H. and Esterbauer H. (1995) The role of neopterin release by macrophages during inflammation. Wollongong, Australia: Society for Free Radical Research, 1 Jan 1995.

• Gieseg SP., Reibnegger G., Wachter H. and Esterbauer H. (1995) The role of neopterin release by monocytes during inflamation. Wollongong, Australia: SFRR Australisia, 1 Jan 1995.

• Gieseg S. (1994) Gibt es Kriterien fur einen erhohten bedarf an vitaminen, elektrolyten und Spuurenelementen in Zielorganen bei normalen Plasmaerten? University of Hohenheim, Germany: Des Wissenschaftlichen Symposiums der Universitat Hohenheim gemeinsam mit der Ges. F. Biofaktoren (Scientific symposium at the University of Hohenheim (Germany) with Geschaft für Biofaktoren), 1 Jan 1994.

• Gieseg S. (1994) The role of free radicals in health and disease. Rotterdam, Netherlands: European Society for Free Radical Research's Spring meeting, 1 Jan 1994.

• Gieseg SP. and Esterbauer H. (1994) Austrian-French Colloquia on Lipoproteins and atherogenesis. Hochgurgl, Austria: Austrian-French Colloquia on Lipoproteins and atherogenesis, 1 Jan 1994.

• Gieseg SP., Ramous P. and Esterbauer H. (1994) Human low density lipoprotein is saturatable by pro-oxidant copper. Sydney, Australia: SFRR International conference, 1 Jan 1994.

• Gieseg S. (1993) Protein bound DOPA is a reductant formed during gamma radiolysis of proteins. Sydney, Australia: The 1st Australian-Asian Radiation Science and Nuclear Medicine Conference, 1 Jan 1993.

• Gieseg S. (1993) Tests of LDL oxidisability. Physiological relevance to heart disease. Londonderry, UK: FLAIR Concerted Action No. 10 Workshop (The measurement of micronutrient Absorption and status) on LDL oxidisability, 1 Jan 1993.

• Gieseg SP. and Esterbauer H. (1993) Effect of antioxidants on oxidative modification of LDL. Wien, Austria: Austrian Biochemistry Society, 1 Jan 1993.

• Gieseg SP., Simpson JA., Charlton T., Duncan M. and Dean RT. (1993) Protein bound DOPA a reductant formed during gamma radiolysis of proteins. Sydney, Australia: 1st Australian-Asian Radiation Science and Nuclear Medicine Conference, 1 Jan 1993.

• Gieseg SP., Simpson JA., Charlton T., Duncan M. and Dean RT. (1993) Protein bound DOPA is the reductant formed during free radical damage to proteins. Australia: Lorne Conference on Protein Structure and Function, 1 Jan 1993.

• Gieseg SP., Simpson JA. and Dean RT. (1992) The nature of bound reducing moieties on radical damaged proteins. Italy: Turin SFRR International Conference, 1 Jan 1992.

• Gieseg S. (1991) The formation of reductive species on radical damaged protein. Christchurch, New Zealand: The combined New Zealand Institute of Chemistry and New Zealand Biochemistry Society 1991 Conference, 1 Jan 1991.

• Gieseg SP., Grigor MR. and Carne A. (1991) Characterisation of ovine pancreatic lipase by primary sequence analysis and production of a polyclonal antibody. Australia: 16th Lorne Protein Conference, 1 Jan 1991.

• Gieseg SP., Simpson JA. and Dean RT. (1991) Long lived reductive species on free radical damaged proteins. Perth, Australia: Atherosclerosis Society Conference, 1 Jan 1991.

• Gieseg SP., Simpson JA. and Dean RT. (1991) The formation of long lived reductive species on free radical damaged proteins. Australia: Society for Free Radical Research (Australasia) 1991 Lorne Conference, 1 Jan 1991.

• Gieseg SP., Simpson JA. and Dean RT. (1991) The formation of long lived reductive species on free radical damaged proteins. Christchurch, New Zealand: New Zealand Institute of Chemistry/New Zealand Biochemistry Society 1991 Conference, 1 Jan 1991.

• Gieseg S. (1988) Characterisation of ovine pancreatic lipase. Dunedin, New Zealand: Proceedings of the University of Otago Medical School, 1 Jan 1988.

• Gieseg SP. and Carne A. (1988) Characterization of ovine pancreatic lipase. Dunedin, New Zealand: University of Otago Medical School, 1 Jan 1988.

Oral Presentations

• Gieseg SP., Healy JL., Prebble HM., Panta RK., Raja A., de Ruiter NJA., bateman CJ., Walsh MF., Bell ST. and Anderson NG. (2017) Spectral Imaging of Unstable Atherosclerotic plaque by MARS-Scanning. CERN, Geneva, switzerland: Medical Applications of Spectroscopic X-ray detectors, 16 May 2017.

• Gieseg SP. (2014) Macrophage antioxidants and death. University of Lincoln, Faculty of Agriculture and Life Sciences.

• Gieseg SP. (2014) Macrophage cell death in atherosclerlerosis. Department of Biochemistry, University of Otago, Dunedin.

• Gieseg SP. (2014) Vascular disease, why do we need better imaging? Christchurch Hospital, New Zealand: Canterbury Combined Sonographer Continuing Education Meeting.

• Gieseg SP. (2012) Colour Ct-imaging of excised atherosclerotic plaque using MARS-CT: A preview of the future. University of Auckland, New Zealand: Maurice Wilkins Centre Symposium on "New ways to image the body - from macro to nano".

• Gieseg SP. (2011) Oxidative stress and 7,8-Dihydroneopterin in atherosclerosis. Exeter, United Kingdom: Institute of Biomedical and Clinical Science, Peninsula Medical School, St. Luke's Campus, Exeter.

• Gieseg SP. (2011) Oxidative stress and 7,8-Dihydroneopterin in atherosclerosis. Innsbruck, Austria: Biozentrum, Sektion fur Biologishe Chemie Mediziische Universitat Innsbruck.

• Gieseg SP. (2010) Cell death in advanced atherosclerotic plaque. Christchurch School of Medicine, New Zealand: Monday Seminar Series.

• Gieseg S. (2009) Macrophage cell death and 7,8-dihydroneopterin. Biozentrum, Sektion f�r Biologishe Chemie Mediziische Universit�t Innsbr�ck, Austria.

• Gieseg S. (2009) Radical Death by Cholesterol. School of Biological Sciences, University of Canterbury, Christchurch, New Zealand: Faculty Research Seminar Series.

• Gieseg SP. (2009) Inhibition of OxLDL mediated macrophage necrosis by down regulation of OxLDL uptake, CD36 expression and intracellular oxidant production by 7,8-Dihydroneopterin. St. Christoph, Arlberg: 28th International Winter-Workshop on Clinical, Chemical and Biochemical Aspects of Pteridines.

• Gieseg SP. (2009) Modeling oxLDL induced macrophage cell death in tissue culture. The Department of Anatomy, Auckland School of Medicine, New Zealand: Departmental Seminar, 01 Jan 2007.

• Gieseg SP. (2009) Neopterin and Radical Death by Cholesterol. Canterbury Health Laboratory, Christchurch, New Zealand: Departmental Seminar, 25 Sep 2009.

• Gieseg SP. (2008) Modulation of atherosclerotic plaque formation by the macrophage antioxidant 7,8-dihydroneopterin. University of Otago, Dunedin, New Zealand: Department of Toxicology and Pharmacology Seminar (Invited), 04 Jul 2008.

• Gieseg SP. (2007) Macrophage antioxidants as controllers of atherosclerotic plaque formation. Christchurch Hospital, Christchurch, New Zealand: Department of Surgery Seminar, 24 Apr 2008.

• Gieseg SP. (2007) Macrophage cell death during atherosclerosis. St Luke's Campus, Exeter, UK: Peninsula Medical School Seminar, 01 Aug 2007.

• Gieseg S. (2006) Macrophage antioxidants as controllers of atherosclerotic plaque formation. Centre for Bioengineering, University of Canterbury, Christchurch, New Zealand: 01 Jan 2006.

• Gieseg S. (2006) Macrophage oxidants as determinates of atherosclerotic plaque formation. Malaghan Institute of Medical Research, Wellington, New Zealand: Invited seminar, 01 Sep 2006.

• Gieseg S. (2006) Macrophage oxidants as drivers of atherosclerotic plaque formation. Agriculture and Life Sciences Division, Lincoln University, Christchurch, New Zealand: Invited seminar, 01 Jan 2006.

• Gieseg S. (2005) Heart Disease: When Good Cells Go Bad. The School of Biological Sciences: 01 Jan 2009.

• Gieseg S. (2005) Heart Disease: When Macrophages Go Bad. The Christchurch School of Medicine: 01 Dec 2005.

• Gieseg S. (2005) Role of a cellular antioxidant in the progression of atherosclerosis. Department of Life Sciences, Kings College, London, UK: 01 Jan 2008.

• Gieseg S. (2005) Role of a cellular antioxidant in the progression of atherosclerosis. Medizinische Universit�t Graz, Austria: 19 Oct 2006.

• Gieseg S. (2005) Role of a cellular antioxidant in the progression of atherosclerosis. MRC Dunn Human Nutrition Unit, Cambridge, UK: 30 May 2007.

• Gieseg S. (2005) Role of a cellular antioxidant in the progression of atherosclerosis. School of Animal and Microbiolial Science, University of Reading, UK: 11 May 2009.

• Gieseg S. (2005) Role of a cellular antioxidant in the progression of atherosclerosis. The School of Food Science, University of Reading, UK: 20 Mar 2009.

• Gieseg S. (2002) Billboard (Television Interview) Canterbury TV (CTV), interview with Donna Gibon. .

• Gieseg S. (2002) White blood cells (the role of white blood cells in heart disease) For "EUREKA" science show on Radio New Zealand. .

• Gieseg S. (2001) 7,8 dihydroneopterin antioxidant protection of macrophages during inflammation and heart disease. Christchurch Medical School, Christchurch, New Zealand.

• Gieseg S. (2001) Antioxidant protection of Macrophage cells. University of Canterbury, Christchurch, New Zealand.

• Gieseg S. (2001) Protection of cellular proteins from free radical damage by the macrophage antioxidant 7,8-dihydroneopterin. University of Otago, Dunedin, New Zealand.

• Gieseg S. (1995) Invited Seminar. Department of Biochemistry, University of Otago, Dunedin, New Zealand: 18 May 2009.

• Gieseg S. (1995) The role of anti-oxidants and protein oxidation in free radical mediated pathology with emphasis on atherosclerosis. Department of Zoology, University of Canterbury, Christchurch, New Zealand: 22 May 2009.

• Gieseg S. (1994) The role of neopterin release by monocytes during inflammation. Institute of Biochemie, University of Graz, Austria: 20 May 2008.

• Gieseg S. (1993) The formation of protein by reactive groups during free radical attack on proteins. Institute of Biochemistry, University of Graz, Graz, Austria: 23 Jun 2009.

• Gieseg S. (1992) Protein oxidation as a marker and mechanism in disease processes, (Interaction of free radicals with protein bound DOPA). Pathology Department of the University of Christchurch, New Zealand: 07 May 2009.

• Gieseg S. (1992) Redox activity of protein bound DOPA. Heart Research Institute, Sydney, Australia: 21 Nov 2008.

• Gieseg S. (1990) 1990-1992 Four presentations to the Heart Research Institute, Sydney, Australia, on protein bound -reactive groups. 20 Mar 2009.

• Gieseg S. (1990) The purification and characterisation of ovine pancreatic lipase. Biochemistry, University of Otago, Dunedin, New Zealand: 25 Nov 2008.

• Gieseg S. (1990) The purification and characterisation of ovine pancreatic lipase. The Heart Research Institute, Sydney, Australia: 06 Mar 2009.

• Gieseg S. (1989) Purification of ovine pancreatic lipase. Departments of Biochemistry and Microbiology, University of Otago, Dunedin, New Zealand: 12 Jun 2009.

• Gieseg S. (1985) B.Sc. Honours degree seminar, "The autonomous and environmental factors regulating the hatching of encysted Artemia salina". Department of Biochemistry, University of Otago, Dunedin, New Zealand: 25 May 2009.

Reports

• Gieseg S. (2001) Exploring the radical nature of heart disease.Commissioned by 48pp.

• Gieseg S. (1998) Fighting Free Radicals.Commissioned by 43-44.

Review and Refereeing

• Atherosclerosis ( 2006 - 2011)
• Biochimica et Biophysica Acta ( 2006 - 2011)
• Biochimica et Biophysica Acta ( 1997 - 2002)
• Biophysica Acta ( 2006 - 2019)
• Canadian Journal of Zoology ( 2006 - 2019)
• Canadian Journal of Zoology ( 2006 - 2011)
• Canadian Journal of Zoology ( 1997 - 2002)
• Carbohydrate Research ( 2006 - 2011)
• Chemical Research in Toxicology ( 2006 - 2011)
• Clinica Chimica Acta ( 2006 - 2011)
• Clinical Chemistry ( 2006 - 2019)
• Clinical Chemistry ( 2006 - 2011)
• Clinical Chemistry ( 1997 - 2002)
• Comparative Biochemistry and Physiology ( 2006 - 2011)
• Current Medical Chemistry ( 2006 - 2011)
• Diabetes Research and Clinical Practice ( 2006 - 2019)
• Diabetes Research and Clinical Practice ( 2006 - 2011)
• Diabetes Research and Clinical Practice ( 1997 - 2002)
• Food Chemistry ( 2006 - 2011)
• Free Radical Biology and Medicine ( 2006 - 2011)
• Free Radical Research ( 2006 - 2019)
• Free Radical Research ( 2006 - 2011)
• Free Radical Research ( 1997 - 2002)
• International Journal of Biochemistry and Cell Biology ( 2006 - 2019)
• International Journal of Biochemistry and Cell Biology ( 2006 - 2011)
• Journal of Agricultural and Food Chemistry ( 2006 - 2011)
• Journal of Cell Biology ( 2006 - 2011)
• Journal of Lipid Research ( 2006 - 2011)
• Journal of Pharmacy and Pharmacology ( 2006 - 2019)
• Journal of Pharmacy and Pharmacology ( 2006 - 2011)
• Journal of Pharmacy and Pharmacology ( 1997 - 2011)
• Life Sciences ( 2006 - 2019)
• Life Sciences ( 2006 - 2011)
• Life Sciences ( 1997 - 2011)
• Lipids ( 2006 - 2011)
• Redox Report ( 2006 - 2011)
• Redox Report ( 1997 - 2002)

Research Groups

Future Research

• Spectral Medical Imaging of heart disease and stroke
• Measurement of clinical inflammation
• Macrophage Biochemistry in plaque